Aflatoxin Beta1 Aldehyde Reductase (AKR7A2) (N-Term) Peptide
Quick Overview for Aflatoxin Beta1 Aldehyde Reductase (AKR7A2) (N-Term) Peptide (ABIN973080)
Target
Origin
Source
Application
-
-
Protein Region
- N-Term
-
Sequence
- SETILGGLGL GLGGGDCRVK IATKANPWDG KSLKPDSVRS QLETSLKRLQ
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-AKR7A2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- AKR7A2 (Aflatoxin Beta1 Aldehyde Reductase (AKR7A2))
-
Background
-
The protein encoded by this gene belongs to the aldo/keto reductase (AKR) superfamily and AKR7 family, which are involved in the detoxification of aldehydes and ketones. The AKR7 family consists of 3 genes that are present in a cluster on the p arm of chromosome 1. This protein, thought to be localized in the golgi, catalyzes the NADPH-dependent reduction of succinic semialdehyde to the endogenous neuromodulator, gamma-hydroxybutyrate. It may also function as a detoxication enzyme in the reduction of aflatoxin B1 and 2-carboxybenzaldehyde.
Alias Symbols: AFAR, AFAR1, AFB1-AR1, AKR7
Protein Interaction Partner: AKR7A3,F2,AKR7A3,TRIM63,UBC
Protein Size: 359 -
Molecular Weight
- 39 kDa
-
Gene ID
- 8574
-
NCBI Accession
- NM_003689, NP_003680
-
UniProt
- O43488
Target
-